Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
clinical trials
life sciences
national blog main
svb leerink
2
×
abbvie
alkermes
allergan
andrew berens
avapritinib
biotech
blueprint medicines
boston
boston top stories
buprenorphine
cancer
cariprazine
deciphera pharmaceuticals
eli lilly
europe
europe blog main
europe top stories
fda
felipe jain
gastrointestinal stromal tumor
gist
gleevec
imatinib
jess fiedorowicz
jessica jeffrey
karim calis
lumateperone
m health fairview
marc goodman
massachusetts general hospital
national institutes of health (nih)
national top stories
olanzapine
opioid
ottawa hospital
What
drug
fda
medicine
2
×
alkermes
announced
antipsychotic
approval
benefits
blueprint
cancer
caveats
chasing
commonly
deadly
deciphera
designed
effect
favor
filing
forms
gain
gi
morning
offer
panel
pharamceuticals
plans
prescribed
psyche
seek
treatment
treats
tumor
type
vote
weighs
weight
won
Language
unset
2
×
Current search:
unset
×
" svb leerink "
×
medicine
×
@xconomy.com
3 years ago
FDA Panel Vote Weighs in Favor of Alkermes Psyche Drug, With Caveats
@xconomy.com
4 years ago
Chasing Blueprint, Deciphera Plans FDA Filing for GI Cancer Drug
